News

Filter

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

Helsinn gains exclusive rights to commercialize Pharmacosmos' Monofer in the USA

08-01-2015

Swiss oncology specialist Helsinn and Danish anemia drugmaker Pharmacosmos have entered into an agreement…

HelsinnHematologyLicensingMarkets & MarketingMonoferPharmaceuticalPharmacosmos

Plasma fractionation market forecasts to 2019

06-01-2015

The global plasma fractionation market is witnessing continuous growth. The rise in aging population…

Baxter InternationalBio Product LaboratoryBiotestCSL LtdGlobalGrifolsHematologyKedrionLFB BiotechnologiesMarkets & MarketingOctapharmaPharmaceuticalSanquin

SOBI and Pharming extend and amend Ruconest agreement

SOBI and Pharming extend and amend Ruconest agreement

13-10-2014

Biotech companies Pharming Group and Swedish Orphan Biovitrum have amended and extended the Ruconest…

BiotechnologyHematologyMarkets & MarketingPharmingRuconestSobiSweden

Biogen Idec’s long-acting agents to have major impact on hemophilia market

Biogen Idec’s long-acting agents to have major impact on hemophilia market

14-08-2014

The hemophilia treatment landscape is to undergo a radical shift away from established short-acting therapies,…

AlprolixBiogen IdecBiotechnologyCoagulation systemEloctateEuropeHematologyHemophilia treatmentJapanMarkets & MarketingRecombinant proteinsRFIX productsSwedish Orphan BiovitrumUSA

Novartis’ Glivec could lose half patient population in China to generics

Novartis’ Glivec could lose half patient population in China to generics

03-06-2014

Hematologists in China estimate that Glivec (imatinib) from Swiss drug major Novartis will lose nearly…

Blast phase CMLChemistryChinaChronic phase CMLGlivecHealth Medical PharmaHematologyMajorMarkets & MarketingNovartisPharmaceutical

Genentech regains its dominance in image among oncologists

Genentech regains its dominance in image among oncologists

20-02-2014

Genentech, the biotechnology subsidiary of Swiss drug major Roche, has made notable gains as the top…

AmgenBiotechnologyCelgeneGenentechHematologyMarkets & MarketingNovartisOncologyResearch

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

10-01-2014

Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

COMPANY SPOTLIGHT

Menarini

Back to top